Single and Multiple Oral Administration Study of ASP015K in Healthy Nonelderly Volunteers
NCT01225224 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 72
Last updated 2024-10-16
Summary
A study to evaluate the safety, tolerability and PK profiles of single and multiple doses of ASP015K in healthy nonelderly men.
Conditions
- Pharmacokinetics of ASP015K
- Healthy Volunteer
Interventions
- DRUG
-
peficitinib
oral
- DRUG
-
oral
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Use Central Contact · Astellas Pharma Inc
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 44 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-11-18
- Primary Completion
- 2010-03-10
- Completion
- 2010-03-10
Countries
- Japan
More Related Trials
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K
NCT01387087 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Subjects
NCT02500953 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Pharmacokinetics Study of ASP0456 in Healthy Subjects
NCT01279915 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects
NCT02141425 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects
NCT01872013 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects
NCT02155504 ·Status: COMPLETED ·Phase: PHASE1
-
Study of ASKP1240 After a Single Intravenous Dose at Escalating Dose Levels in Healthy Subjects
NCT01565681 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects
NCT02140125 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy Japanese Adult Subjects
NCT03108755 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects
NCT01427387 ·Status: COMPLETED ·Phase: PHASE1
-
First in Men Study of Single Oral Doses of ASP1941 in Healthy Subjects
NCT01288885 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers
NCT00687232 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Pharmacological Effect and Plasma Concentration of ASP7991 After Single Oral Administration to Healthy Volunteers
NCT01675518 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females and Elderly Females and to Evaluate the Effect of Food on the Pharmacokinetics of a Single Dose of of ASP2205
NCT02314793 ·Status: TERMINATED ·Phase: PHASE1
-
ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects
NCT03361540 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female Subjects
NCT03183739 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3700 in Healthy Subjects
NCT02285465 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect
NCT04077879 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effects of Single Ascending Doses of ASP1707 in Healthy Young Japanese Male Subjects
NCT02146742 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants
NCT04878471 ·Status: COMPLETED ·Phase: PHASE1
-
Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236
NCT00767052 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability and Pharmacokinetics After Single Dose of AZD2516 to Japanese Healthy Subjects
NCT00972049 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects
NCT02125435 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants
NCT06502379 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male Subjects
NCT03435276 ·Status: COMPLETED ·Phase: PHASE1